Tender

Online Pharmaceutical Intelligence Platform

  • Medicines Discovery Catapult

F02: Contract notice

Notice identifier: 2021/S 000-024174

Procurement identifier (OCID): ocds-h6vhtk-02e5dd

Published 29 September 2021, 11:03am



Section one: Contracting authority

one.1) Name and addresses

Medicines Discovery Catapult

Block 35, Mereside, Alderley Park

Cheshire

SK10 4TG

Contact

Mrs Susan Syder

Email

susan.syder@md.catapult.org.uk

Telephone

+44 1625238734

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

https://md.catapult.org.uk/

Buyer's address

https://md.catapult.org.uk/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://procontract.due-north.com/Advert/Index?advertId=a5a1cdf5-0721-ec11-810e-005056b64545

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://procontract.due-north.com/Advert/Index?advertId=a5a1cdf5-0721-ec11-810e-005056b64545

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Online Pharmaceutical Intelligence Platform

Reference number

DN572894

two.1.2) Main CPV code

  • 73000000 - Research and development services and related consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

Access to an online platform which will used to identify and analyse data relating to companies, drugs (pipeline and marketed), diagnostic, biomarkers, clinical trials, diagnostics development and epidemiology.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Access to an online platform which will used to identify and analyse data relating to companies, drugs (pipeline and marketed), diagnostic, biomarkers, clinical trials, diagnostics development and epidemiology.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start date

1 January 2022

This contract is subject to renewal

Yes

Description of renewals

Initial contract period is for 15 months with an option to extend for a further 36 months

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

1 November 2021

Local time

12:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tenders

Date

1 November 2021

Local time

12:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

Medicines Discovery Catapult

Cheshire

Email

susan.syder@md.catapult.ork.uk

Country

United Kingdom